SCHEMBL979849

SCHEMBL979849

CCOC(=O)CC1(N)CN(C(=O)O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
KMT2A Q03164 1/20 0.44
ALOX15 P16050 2/20 0.41
GAA P10253 3/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
ALDH1A1 P00352 4/20 0.36
TRPA1 O75762 1/20 0.36
CYP1A2 P05177 1/20 0.36
TSHR P16473 3/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
ELANE P08246 1/20 0.34
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980236 0.87 L3MBTL1 (0.40) L3MBTL1KMT2AALOX15GAAMGAM
SCHEMBL16761878 0.84 TP53 (0.34) L3MBTL1ALOX15GAAMGAMSI
SCHEMBL23326568 0.82 KMT2A (0.47) L3MBTL1KMT2AALOX15GAAMGAM
SCHEMBL980372 0.79 ADORA1 (0.39) L3MBTL1KMT2AALOX15GAAMGAM
SCHEMBL21981429 0.77 KMT2A (0.38) L3MBTL1KMT2AALOX15GAAMGAM
SCHEMBL16276877 0.77 GAA (0.48) L3MBTL1KMT2AALOX15GAAMGAM
SCHEMBL23112773 0.77 ALDH1A1 (0.33) ALDH1A1POLB
SCHEMBL21777722 0.76 ALOX15 (0.38) L3MBTL1KMT2AALOX15GAAMGAM
SCHEMBL15774716 0.76 SMN1; SMN2 (0.48) L3MBTL1KMT2AGAAALDH1A1TSHR
Hydrochloric Acid SCHEMBL29267183 0.75 GAA (0.46) L3MBTL1KMT2AALOX15GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680282-B2 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer UNIVERSITY HEALTH NETWORK (CA) 2014-03-25 US disclosed
US-20110015174-A1 CYCLIC INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER UNIVERSITY HEALTH NETWORK (CA) 2011-01-20 US disclosed
WO-2009015485-A1 CYCLIC INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER UNIVERSITY HEALTH NETWORK (CA) 2009-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015174-A1 CYCLIC INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER CPT1A, CPT1B, CPT2 L3MBTL1 2605/4885KMT2A 1063/4885ALOX15 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.